TM 30339

Drug Profile

TM 30339

Alternative Names: TM30339

Latest Information Update: 23 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator 7TM Pharma
  • Class Obesity therapies; Peptides
  • Mechanism of Action Neuropeptide Y4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Gastrointestinal disorders; Obesity

Most Recent Events

  • 23 Apr 2010 Pharmacodynamics data from a Preclinical trial in Gastrointestinal disorders released by 7TM Pharma
  • 02 Sep 2008 Phase-I/II clinical trials in Obesity in USA (Parenteral)
  • 12 Mar 2007 Preclinical data added to the Obesity pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top